Global Isothermal Nucleic Acid Amplification Market Trends 2024, Forecast To 2033
16 Jan, 2024
Isothermal nucleic acid amplification technology (INAAT) market size rose from $3.53 billion in 2023 to $3.91 billion in 2024 at a 10.7% CAGR. Historic growth can be attributed to infectious disease diagnostics, point-of-care testing (POCT), tuberculosis control, molecular diagnostics, and emerging markets. Projected to reach $6.39 billion in 2028 at a 13.1% CAGR, the forecast period highlights pandemic preparedness, antimicrobial resistance, environmental monitoring, oncology diagnostics, and global health initiatives. Trends include multiplexing, miniaturization, digital detection, sample-to-answer systems, and gene editing integration.
Global Isothermal Nucleic Acid Amplification Market Key Driver
The escalating incidence of infectious and chronic diseases drives the Isothermal Nucleic Acid Amplification Technology (INAAT) market. INAAT is crucial for diagnosing infectious diseases like tuberculosis. The World Health Organization estimates 10 million annual tuberculosis infections, emphasizing the need for INAAT. The rising incidence of infectious and chronic diseases contributes to the growth of the INAAT market.
Get A Free Sample Of The Global Isothermal Nucleic Acid Amplification Market ReportGlobal Isothermal Nucleic Acid Amplification Market Segments
The isothermal nucleic acid amplification technology (inaat) market covered in this report is segmented –
1) By Product: Instrument, Reagent
2) By Technology: NASBA, HAD
3) By Application: Blood Screening, Infectious Disease Diagnostics, Cancer
4) By End-User: Hospital, Reference Laboratories, Other End-Users
By Geography: The regions covered in the isothermal nucleic acid amplification market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions
North America was the largest region in the isothermal nucleic acid amplification technology (INAAT) market in 2023. Western Europe was the second largest region in the isothermal nucleic acid amplification technology (INAAT) market. The regions covered in the isothermal nucleic acid amplification technology (inaat) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Isothermal Nucleic Acid Amplification Industry Players
Alere Inc., biomeriux SA, Qiagen NV, Becton, Dickson & Company, Hologica Inc., Lucigen Corporation, Quidel Corporation, New England Biolabs Inc., NuGen, Ustar Biotechnologies Ltd., Thermo Fisher Scientific Inc., BioHelix Corporation, Meridian Bioscience Inc., Novartis AG, Sharp Corporation, Sony Corporation, Panasonic Holdings Corporation, Toshiba Corporation, Rohm Co Ltd., PhilipsHologic-Gen-Probe, BetaLED, Avago Technologies Ltd., Grifols SA, Abbott Laboratories, Jena Bioscience GmbH, Atila Biosystems Incorporated, TwistDx Ltd., LGC Ltd., DiaSorin SpA, OptiGene Limited
Get The Full Global Isothermal Nucleic Acid Amplification Market ReportIsothermal Nucleic Acid Amplification Market Overview
Isothermal nucleic acid amplification technology (INAAT) is a technique that amplifies DNA samples. Isothermal nucleic acid amplification technologies are used to amplify DNA sequences from two different nucleic acid segments at a constant temperature.
Isothermal Nucleic Acid Amplification Global Market Report 2023 provides data on the global isothermal nucleic acid amplification market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The isothermal nucleic acid amplification market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.